Borah, Victor M
Agonists Exendin-4 (subsequently renamed exenatide, the first FDA approved incretin mimetic), Liraglutide (a longacting DPP-4-resistant GLP-1 receptor agonist), CJC-1131 (a GLP-1 analog engineered for covalent coupling to albumin), Albiglutide (originally referred to as albugon, a recombinant human albumin-GLP-1 protein), ZP10 (an exendin-4 derivative), BIM51077 (subsequently renamed taspoglutide), LY315902 (a DPP-4-resistant GLP-1 analog), LY2428757 (a pegylated GLP-1), LY2199265 (Dulaglutide, an Fc immunoglobulin fusion protein), Semaglutide (a synthetic peptide similar to GLP-1), Lixisenatide (a synthetic peptide similar to exandin-4), and Tirzepatide (LY3298176, a dual agonist of GIP and GLP-1 receptors)
By supporting healthy metabolic function and appetite control, Retatrutide may help reduce body weight and improve overall energy levels when used along with a healthy diet and lifestyle plan
To make it injectable, you dissolve it in bacteriostatic water (BAC water) to create a solution at a specific concentration
Calorically dense substances, including alcohol, carry reinforcing properties going beyond their central nervous system effects
Basic Clin Pharmacol Toxicol (2018) 122(6):55969